|
|
|
|
| LEADER |
02112 am a22003013u 4500 |
| 001 |
99479 |
| 042 |
|
|
|a dc
|
| 100 |
1 |
0 |
|a Young, Carissa L.
|e author
|
| 100 |
1 |
0 |
|a Massachusetts Institute of Technology. Center for Gynepathology Research
|e contributor
|
| 100 |
1 |
0 |
|a Massachusetts Institute of Technology. Department of Biological Engineering
|e contributor
|
| 100 |
1 |
0 |
|a Ebrahimkhani, Mohammad Reza
|e contributor
|
| 100 |
1 |
0 |
|a Young, Carissa L.
|e contributor
|
| 100 |
1 |
0 |
|a Lauffenburger, Douglas A.
|e contributor
|
| 100 |
1 |
0 |
|a Griffith, Linda G.
|e contributor
|
| 700 |
1 |
0 |
|a Lauffenburger, Douglas A.
|e author
|
| 700 |
1 |
0 |
|a Griffith, Linda G.
|e author
|
| 700 |
1 |
0 |
|a Borenstein, Jeffrey T.
|e author
|
| 700 |
1 |
0 |
|a Ebrahimkhani, Mohammad Reza
|e author
|
| 245 |
0 |
0 |
|a Approaches to in vitro tissue regeneration with application for human disease modeling and drug development
|
| 260 |
|
|
|b Elsevier,
|c 2015-10-27T17:40:25Z.
|
| 856 |
|
|
|z Get fulltext
|u http://hdl.handle.net/1721.1/99479
|
| 520 |
|
|
|a Reliable in vitro human disease models that capture the complexity of in vivo tissue behaviors are crucial to gain mechanistic insights into human disease and enable the development of treatments that are effective across broad patient populations. The integration of stem cell technologies, tissue engineering, emerging biomaterials strategies and microfabrication processes, as well as computational and systems biology approaches, is enabling new tools to generate reliable in vitro systems to study the molecular basis of human disease and facilitate drug development. In this review, we discuss these recently developed tools and emphasize opportunities and challenges involved in combining these technologies toward regenerative science.
|
| 520 |
|
|
|a National Institute for Biomedical Imaging and Bioengineering (U.S.) (Grant 5R01EB010246-02)
|
| 520 |
|
|
|a National Center for Advancing Translational Sciences (U.S.) (Grant 1UH2TR000496)
|
| 520 |
|
|
|a United States. Defense Advanced Research Projects Agency (Cooperative Agreement W911NF-12-2-0039)
|
| 546 |
|
|
|a en_US
|
| 655 |
7 |
|
|a Article
|
| 773 |
|
|
|t Drug Discovery Today
|
